Why This Landed on My Radar
We’re all watching Medicare reimbursement rates erode year after year, but here’s a case study that shows where this ends up: ophthalmologists are now routinely charging patients $2,000+ out-of-pocket for laser-assisted cataract surgery when the scalpel method works just fine. Medicare cut their reimbursement 20% over a decade, so they found a workaround - and it’s perfectly legal. This matters because it’s a preview of what happens when the government squeeze gets tight enough: physicians start shifting revenue to patient-pay services whether the clinical benefit justifies it or not.
Here’s What’s Going On
Medicare pays ophthalmologists about $520 for standard cataract surgery today - down roughly 20% from a decade ago. That fee includes pre- and post-op visits for one of the most common procedures in the Medicare population. In response, a growing number of eye surgeons are encouraging patients to pay extra for laser-assisted cataract surgery instead of the traditional scalpel method.
Patients like Tammy Chalala, a 69-year-old retired dietitian in New York, are paying nearly $4,000 out-of-pocket for both eyes because they believe the laser offers better outcomes. The laser equipment itself costs practices up to $500,000, so there’s significant capital investment to recoup. While Medicare generally prohibits balance billing, there’s a carve-out that allows doctors to charge patients extra when using the laser or providing premium intraocular lenses.
Here’s the clinical reality: both methods are safe and effective. Dr. Oliver Schein, an ophthalmologist at Johns Hopkins Medicine, notes his colleagues tried the laser when it first came out but didn’t see any benefit over traditional surgery. The laser doesn’t cause harm and produces good results, but so does the scalpel. Many surgeons argue the laser makes more precise cuts and gives patients more options, but the research doesn’t show a meaningful clinical advantage for most patients.
What This Means for Your Practice
This is our future if we don’t pay attention. We’re in primary care, not ophthalmology, but the playbook is identical: Medicare and commercial payers squeeze reimbursement, and physicians respond by finding patient-pay revenue streams to keep the lights on.
In Texas, we’re already dealing with the worst possible payer mix. We have the largest uninsured population in the country, no Medicaid expansion, and commercial rates that haven’t kept pace with inflation. BCBS Texas and United Healthcare dominate our market, and neither is exactly generous with rate updates. Our Medicare Advantage penetration keeps growing - which means more patients under risk-adjusted contracts where our HCC capture directly impacts our revenue.
The ophthalmology story shows what happens when the math stops working: you either find ancillary revenue or you close. For them, it’s lasers and premium lenses. For us, it might be GLP-1 programs, chronic care management, annual wellness visits we’re not capturing, or other services where we can either bill properly or create patient-pay models.
But here’s the uncomfortable question: are we offering these services because they genuinely improve outcomes, or because we need the revenue? The ophthalmologists can make a reasonable case that laser surgery gives patients more options and peace of mind, even if the clinical benefit is marginal. We need to ask ourselves the same question about every revenue enhancement strategy we consider.
The good news is primary care actually has better options. Proper HCC documentation isn’t upselling - it’s accurate coding that reflects how sick our patients really are. CCM and RPM programs, when done right, genuinely improve outcomes for chronically ill patients. GLP-1s are transformative for the right patients, and managing them in-house creates better continuity than punting to endocrinology.
The risk is letting the revenue pressure push us toward services that don’t add real value. We’re better than that, but we also can’t ignore the economics.
Key Takeaways
- Medicare reimbursement for common procedures has dropped 20% in a decade - expect this trend to continue across specialties
- Specialists are responding by shifting to patient-pay services with questionable incremental clinical benefit
- Texas practices face additional pressure from high uninsured rates, no Medicaid expansion, and tough commercial payers
- Primary care has legitimate revenue opportunities (HCC capture, CCM, GLP-1 management) that actually improve care
- The key is choosing revenue strategies that align clinical value with financial sustainability - not just chasing patient-pay add-ons
What Smart Practices Are Doing
The best independent practices are auditing their revenue cycle to find legitimate money they’re leaving on the table - proper E&M coding, HCC documentation that reflects true patient complexity, and care management services that improve outcomes while generating revenue. They’re not inventing new patient-pay services; they’re getting paid properly for the complex work they’re already doing.
Source
Medicare’s Paying Less for Cataract Surgery. Eye Doctors Are Turning to Lucrative Lasers. - KFF Health News
Primary Care Perspective delivers curated intelligence from trusted healthcare sources.
© 2026 Primary Care Perspective | Texas Edition